TNDM
Tandem Diabetes Care IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.24B
P/E Ratio
—
EPS
$-3.04
Beta
1.74
52W High
$29.65
52W Low
$9.98
50-Day MA
$21.78
200-Day MA
$17.97
Dividend Yield
—
Profit Margin
-20.20%
Forward P/E
1111.11
PEG Ratio
0.00
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $1.01B |
| Gross Profit (TTM) | $546.01M |
| EBITDA | $-60.46M |
| Operating Margin | 2.86% |
| Return on Equity | -97.90% |
| Return on Assets | -5.28% |
| Revenue/Share (TTM) | $15.08 |
| Book Value | $2.27 |
| Price-to-Book | 8.22 |
| Price-to-Sales (TTM) | 1.23 |
| EV/Revenue | 1.407 |
| EV/EBITDA | 345.75 |
| Quarterly Earnings Growth (YoY) | -37.00% |
| Quarterly Revenue Growth (YoY) | 2.70% |
| Shares Outstanding | $68.50M |
| Float | $62.60M |
| % Insiders | 0.75% |
| % Institutions | 110.65% |
Historical Volatility
HV 10-Day
55.36%
HV 20-Day
57.95%
HV 30-Day
60.90%
HV 60-Day
87.63%
HV Rank
34.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($31.19 target)
3
Strong Buy9
Buy11
HoldData last updated: 4/30/2026